Stock Scorer

Personalis, Inc. (PSNL) · Insider trading

What Personalis's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$2.74M
1 insider, 12 trades
Sold, 12 months
$8.78M
4 insiders, 94% under a plan
Net, 12 months
−$6.04M
bought less sold
Latest filing
2026-09-22
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $157,124 sold 2024-12: $50,470 sold 2025-01: $7,104 sold 2025-01 2025-05: $19,186 sold 2025-07: $7,181 sold 2025-07 2025-11: $1.74M bought 2025-11: $1.38M sold 2025-12: $996,108 bought 2026-01: $13,812 sold 2026-01 2026-05: $1.55M sold 2026-06: $2.54M sold 2026-07: $3.02M sold 2026-07 2026-09: $266,916 sold
Bought Sold Largest month: $3.02M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Hall Christopher MDirector, Chief Executive Officer – $4.45M 7 2026-09-18 228,527
Tachibana AaronCFO AND COO – $2.90M 12 2026-09-18 195,902
Tempus Ai, Inc.10% owner $2.74M – 12 2025-12-22 13,039,067
Chen RichardPresident and CMO – $1.61M 7 2026-09-18 169,882
Moore Stephen MichaelSVP and Chief Legal Officer – $54,030 4 2026-09-18 90,257

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-09-18 Tachibana AaronCFO AND COO Sale 2,931 16.22 $47,541 195,902 Form 4
2026-09-18 Hall Christopher MDirector, Chief Executive Officer Sale 7,459 16.22 $120,985 228,527 Form 4
2026-09-18 Chen RichardPresident and CMO Sale 3,998 16.22 $64,848 169,882 Form 4
2026-09-18 Moore Stephen MichaelSVP and Chief Legal Officer Sale 2,068 16.22 $33,543 90,257 Form 4
2026-07-15 Chen RichardPresident and CMO Saleplan 100,000 15.15 $1.51M 173,880 Form 4
2026-07-09 Hall Christopher MDirector, Chief Executive Officer Saleplan 100,000 15.08 $1.51M 235,986 Form 4
2026-06-29 Tachibana AaronCFO AND COO Saleplan 4,982 14.00 $69,748 198,833 Form 4
2026-06-26 Tachibana AaronCFO AND COO Saleplan 51,251 13.18 $675,488 198,833 Form 4
2026-06-26 Hall Christopher MDirector, Chief Executive Officer Saleplan 100,000 13.15 $1.31M 235,986 Form 4
2026-06-04 Tachibana AaronCFO AND COO Saleplan 40,000 12.01 $480,400 198,833 Form 4
2026-05-29 Tachibana AaronCFO AND COO Saleplan 38,799 11.58 $449,292 198,833 Form 4
2026-05-29 Hall Christopher MDirector, Chief Executive Officer Saleplan 80,091 11.02 $882,603 235,986 Form 4
2026-05-28 Hall Christopher MDirector, Chief Executive Officer Saleplan 19,909 11.02 $219,397 235,986 Form 4
2026-01-22 Tachibana AaronCFO AND COO Saleplan 1,201 11.50 $13,812 164,458 Form 4
2025-12-22 Tempus Ai, Inc.10% owner Buy 28,000 8.93 $250,040 13,039,067 Form 4
2025-12-19 Tempus Ai, Inc.10% owner Buy 29,641 8.39 $248,688 13,011,067 Form 4
2025-12-18 Tempus Ai, Inc.10% owner Buy 31,430 7.91 $248,611 12,981,426 Form 4
2025-12-17 Tempus Ai, Inc.10% owner Buy 31,650 7.86 $248,769 12,949,996 Form 4
2025-11-25 Tempus Ai, Inc.10% owner Buy 9,712 10.08 $97,897 12,904,458 Form 4
2025-11-25 Tempus Ai, Inc.10% owner Buy 13,888 11.00 $152,768 12,918,346 Form 4
2025-11-25 Tachibana AaronCFO AND COO Saleplan 103,668 10.78 $1.12M 164,458 Form 4
2025-11-24 Tempus Ai, Inc.10% owner Buy 25,225 9.87 $248,971 12,894,746 Form 4
2025-11-21 Tempus Ai, Inc.10% owner Buy 9,900 8.84 $87,516 12,852,922 Form 4
2025-11-21 Tempus Ai, Inc.10% owner Buy 16,599 9.74 $161,674 12,869,521 Form 4
2025-11-20 Tempus Ai, Inc.10% owner Buy 28,827 8.63 $248,777 12,843,022 Form 4
2025-11-19 Tempus Ai, Inc.10% owner Buy 30,645 8.12 $248,837 12,814,195 Form 4
2025-11-18 Tempus Ai, Inc.10% owner Buy 64,750 7.67 $496,632 12,783,550 Form 4
2025-11-03 Hall Christopher MDirector, PRESIDENT AND CEO Sale 29,612 8.99 $266,212 148,486 Form 4
2025-07-28 Tachibana AaronCFO AND COO Sale 641 6.57 $4,211 164,458 Form 4
2025-07-28 Chen RichardCHIEF MEDICAL OFFICER AND EVP Sale 452 6.57 $2,970 124,505 Form 4
2025-05-16 Chen RichardCHIEF MEDICAL OFFICER AND EVP Sale 910 4.95 $4,504 124,957 Form 4
2025-05-16 Moore Stephen MichaelSVP and Chief Legal Officer Sale 1,675 4.95 $8,291 64,200 Form 4
2025-05-16 Tachibana AaronCFO AND COO Sale 1,291 4.95 $6,390 165,099 Form 4
2025-01-28 Chen RichardCHIEF MEDICAL OFFICER AND EVP Sale 519 5.79 $3,005 123,367 Form 4
2025-01-28 Tachibana AaronCFO AND COO Sale 708 5.79 $4,099 166,390 Form 4
2024-12-16 Tachibana AaronCFO AND COO Sale 6,865 3.82 $26,224 167,098 Form 4
2024-12-16 Moore Stephen MichaelSVP and Chief Legal Officer Sale 1,513 3.82 $5,780 65,875 Form 4
2024-12-16 Chen RichardCHIEF MEDICAL OFFICER AND EVP Sale 4,834 3.82 $18,466 123,886 Form 4
2024-11-18 Chen RichardCHIEF MEDICAL OFFICER AND EVP Sale 921 3.79 $3,491 128,720 Form 4
2024-11-18 Moore Stephen MichaelSVP and Chief Legal Officer Sale 1,693 3.79 $6,416 67,388 Form 4
2 more
2024-11-18 Tachibana AaronCFO AND COO Sale 1,307 3.79 $4,954 173,963 Form 4
2024-11-01 Hall Christopher MDirector, PRESIDENT AND CEO Sale 26,443 5.38 $142,263 178,098 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

12 × option exercise10 × grant or award
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-07-15 Chen RichardPresident and CMO Option exercise M +100,000 2.44 273,880 Form 4
2026-07-09 Hall Christopher MDirector, Chief Executive Officer Option exercise M +100,000 1.61 335,986 Form 4
2026-06-29 Tachibana AaronCFO AND COO Option exercise M +4,982 5.32 203,815 Form 4
2026-06-26 Tachibana AaronCFO AND COO Option exercise M +28,832 9.16 227,665 Form 4
2026-06-26 Tachibana AaronCFO AND COO Option exercise M +22,419 5.32 250,084 Form 4
2026-06-26 Hall Christopher MDirector, Chief Executive Officer Option exercise M +100,000 1.61 335,986 Form 4
2026-06-04 Tachibana AaronCFO AND COO Option exercise M +40,000 9.16 238,833 Form 4
2026-05-29 Tachibana AaronCFO AND COO Option exercise M +38,799 9.16 237,632 Form 4
2026-05-29 Hall Christopher MDirector, Chief Executive Officer Option exercise M +80,091 1.61 316,077 Form 4
2026-05-28 Hall Christopher MDirector, Chief Executive Officer Option exercise M +19,909 1.61 255,895 Form 4
2026-05-12 Eastham KarinDirector Grant or award A +6,250 – 19,756 Form 4/A
2026-05-12 Bowman A BlaineDirector Grant or award A +6,250 – 19,756 Form 4
2026-05-12 Widder Kenneth JDirector Grant or award A +6,250 – 6,250 Form 4
2026-05-12 Myers Woodrow A JrDirector Grant or award A +6,250 – 32,366 Form 4
2026-05-12 Shoff LonnieDirector Grant or award A +6,250 – 37,190 Form 4
2026-05-12 Bloom Olivia KyusukDirector Grant or award A +6,250 – 27,265 Form 4
2026-03-15 Tachibana AaronCFO AND COO Grant or award A +34,375 – 198,833 Form 4
2026-03-15 Hall Christopher MDirector, Chief Executive Officer Grant or award A +87,500 – 235,986 Form 4
2026-03-15 Chen RichardPresident and CMO Grant or award A +46,875 – 173,880 Form 4
2026-03-15 Moore Stephen MichaelSVP and Chief Legal Officer Grant or award A +28,125 – 92,325 Form 4
2026-01-22 Tachibana AaronCFO AND COO Option exercise M +1,201 9.16 165,659 Form 4
2025-11-25 Tachibana AaronCFO AND COO Option exercise M +103,668 9.16 268,126 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Personalis's scores and multiples ›